Structure |
Chemical Name |
CAS |
MF |
|
Cefdinir CP Impurity B |
|
|
|
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
|
Fluconazole Impurity 2 |
|
|
|
Imatinib EP Impurity D Chloride |
|
|
|
Favipiravir Impurity |
|
|
|
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
|
Adsorption of hydrogen sulfide Adsorption of impurities in water filter material |
|
|
|
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
|
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
|
Favipiravir Impurity 14 |
356783-49-8 |
C5HClFN3 |
|
Posaconazole Impurity 93 |
165115-82-2 |
C19H19F2IO2 |
|
4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
|
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
|
GLICLAZIDE IMPURITY F |
|
|
|
ONDANSETRON IMPURITY D |
|
|
|
PERINDOPRIL IMPURITY A |
|
|
|
(E)-Ceftiofur |
120882-20-4 |
C19H17N5O7S3 |
|
Cefmetazole Impurity E |
|
|
|
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid 3-isopropyl 5-(2-hydroxyethyl) ester |
82219-47-4 |
C20H24N2O7 |
|
3-[(3-TRIFLUOROMETHYL)PHENYL]-1-PROPENE |
1813-96-3 |
C10H9F3 |
|
(AS)-A-(2-CHLOROPHENYL)-2,3,6,7-TETRAHYDRO-2-OXO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID METHYL ESTER |
527687-26-9 |
C16H16ClNO3S |
|
2-[2-(2-AMINO-9H-PURIN-9-YL)ETHYL]-1,3-PROPANEDIOL |
104227-86-3 |
C10H15N5O2 |
|
1,4,8,11-Tetrakis[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane |
71089-74-2 |
C38H48N4O8S4 |
|
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
|
REF DUPL: trans-2-Hydroxymethyl-5-(cytosin-1-yl)-1,3-oxathiolane |
139757-68-9 |
C8H11N3O3S |
|
1-Propanol,3-[(1,1-dimethylethyl)amino]-2-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]-oxy]- |
59697-06-2 |
C13H24N4O3S |
|
rac Cetirizine N-Oxide > 70% by HPLC
(Mixture of Diastereomers) |
1076199-80-8 |
C21H25ClN2O4 |
|
(S)-N-Didemethyl Dapoxetine |
147199-40-4 |
C19H19NO |
|
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
|
1-METHYL-4-NITRO-3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID |
139756-00-6 |
C8H11N3O4 |
|
6-Hydroxy Nicorandil |
113743-17-2 |
C8H9N3O5 |
|
trans-Itraconazole |
252964-65-1 |
C35H38Cl2N8O4 |
|
N-(2-Pyridyl)oxamic Acid |
13120-39-3 |
C7H6N2O3 |
|
(trans)-4-Propyl-1-methyl-L-proline |
13380-36-4 |
C9H17NO2 |
|
N-Nordextromethorphan
|
1531-23-3 |
C17H23NO |
|
(S,S,R,R)-Orlistat |
111466-62-7 |
C29H53NO5 |
|
17β-Carboxy-17-desoxy Dexamethasone |
75262-69-0 |
C21H27FO4 |
|
1-(dimethoxymethyl)-3-methoxybenzene |
59276-28-7 |
C10H14O3 |
|
Benazepril impurity A |
|
C24H28N2O5 |
|
3S,4R-4-[phenyl-1-methylpiperidinyl] methanol |
176022-03-0 |
C13H19NO |
|
N-[(n-butylaMino)carbonyl]-4-[(3-Methylphenyl)aMino]-3-pyridinesulfonaMide |
160972-33-8 |
C17H22N4O3S |
|
(R)-N-DeMethyl Dapoxetine |
1202160-36-8 |
C20H21NO |
|
14,15-Dehydro Budesonide |
131918-64-4 |
C25H32O6 |
|
2-(BenzylMethylaMino)-3',4'-dihydroxyacetophenone |
36467-25-1 |
C16H17NO3 |
|
2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine |
1262133-66-3 |
C20H30FN3O9 |
|
Cefotiam Impurity 1 |
2243596-87-2 |
C18H23N9O4S3 |
|
sodium 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)-1-oxidopiperazin-1-yl)ethoxy)acetate |
|
|
|
Brivaracetam Impurity 25 |
10547-88-3 |
C7H12O2 |
|
(S)-N-((R)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
|
Peramivir Impurity 19 |
|
|
|
Diquafosol Impurity 13 |
211448-81-6 |
C18H28N4O29P6 |
|
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
|
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
|
Oxacillin Impurity F |
5053-35-0 |
C19H19N3O4S2 |
|
4-Defluoro-4-hydroxy Gefitinib |
847949-50-2 |
C22H25ClN4O4 |
|
Desethyl Sildenafil |
139755-91-2 |
C20H26N6O4S |
|
N-Desisopropyl-N-forMyl Bisoprolol |
1346602-59-2 |
C16H25NO5 |
|
N-DesMethyl Olopatadine |
113835-92-0 |
C20H21NO3 |
|
10-Keto DextroMethorphan |
57969-05-8 |
C18H23NO2 |
|
ent-Paroxol |
389573-45-9 |
C13H18FNO |
|
Febuxostat Acyl-β-D-glucuronide |
1351692-92-6 |
C22H24N2O9S |
|
Keto Bisoprolol |
864544-37-6 |
C18H29NO5 |
|
Olopatadine Carbaldehyde DISCONTINUED |
1376615-97-2 |
C21H23NO2 |
|
5-Chloro-1-methyl-4-nitroimidazole |
|
C4H4ClN3O2 |
|
Nisoldipine Related Compound II |
|
|
|
5-Chloro-N1-Methylbenzene-1,2-diaMine |
84859-27-8 |
C7H9ClN2 |
|
(1'S,3'S,4'S)-Entecavir IsoMer |
1367369-80-9 |
C12H15N5O3 |
|
Iso Ganciclovir |
86357-09-7 |
C9H13N5O4 |
|
(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester |
629652-40-0 |
C22H19ClN2O5 |
|
2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide |
503155-67-7 |
C46H45N7O2 |
|
O-De(3-fluorobenzyl) Lapatinib |
1268997-70-1 |
C22H21ClN4O4S |
|
5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethylenediol |
112935-92-9 |
C14H20N2O6 |
|
Desloratadine Epoxide |
1346604-23-6 |
C19H19ClN2O |
|
Menaquinone 4 2,3-Epoxide |
72908-86-2 |
C31H40O3 |
|
D-Phenylalanyl Nateglinide |
944746-48-9 |
C28H36N2O4 |
|
Felodipine 3,5-DiMethyl Ester |
91189-59-2 |
C17H17Cl2NO4 |
|
Moxifloxacin Methyl Ester |
721970-35-0 |
C22H26FN3O4 |
|
Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) |
873310-31-7 |
C17H22ClNO |
|
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol) |
139264-69-0 |
C15H23N3O |
|
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE |
384338-23-2 |
C14H22N2 |
|
(R,Z)-2-((R)-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)(carboxy)Methyl)-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
178422-39-4 |
C14H15N5O6S2 |
|
Nicergoline-5-Chloro Analogue |
38536-28-6 |
C24H26ClN3O3 |
|
1-(3-aMino-5-(benzyloxy)-2-hydroxyphenyl)ethanone |
861841-90-9 |
C15H15NO3 |
|
(2RS)-2-Hydroxy-2-[4-(2-Methylpropyl)phenyl]propanoic Acid |
|
C13H18O3 |
|
(3RS)-1,3-Bis[4-(2-Methylpropyl) phenyl]butan-1-one |
|
C24H32O |
|
2-[4-(2-Methylpropyl)phenyl] ethanol |
2143535-25-3 |
C24H32O |
|
1-cyclopropyl-6-fluoro-8-hydroxy-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrobroMide |
1292904-74-5 |
C20H23BrFN3O4 |
|
IMp. K (EP) |
40610-41-1 |
C13H17NO3 |
|
4-(4-fluorobenzoyl)-3-(hydroxyMethyl)benzonitrile |
260371-16-2 |
C15H10FNO2 |
|
Montelukast Impurity H |
851755-56-1 |
C34H32ClNO4S |
|
SalMeterol EP IMpurity F |
1391054-40-2 |
C25H37NO3 |
|
[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-7-yl] |
1391054-73-1 |
C28H27NO4S |
|
(R)-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]Methyl]-1-naphthaleneMethaneaMine Hydrochloride |
1229225-42-6 |
C20H19ClF3N |
|
3(S)-Hydroperoxy Simvastatin |
1092716-44-3 |
C25H38O7 |
|
2(RS)-4-Methyl-1-(3-Methylpyridin-2-yl)-2-phenylpiperazine |
191546-94-8 |
C17H21N3 |
|
5-Methyl-2-(1H-1,2,3-triazol-1-yl)benzoic acid |
1149352-55-5 |
C10H9N3O2 |
|
Palonosetron Impurity 7 |
177932-92-2 |
C18H24N2O |
|
4-(2,3-Dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3,5-dicarboxylic acid |
138279-32-0 |
C15H13Cl2NO4 |
|
IMp. A (EP) as Hydrochloride: 3-[[[2-[(DiaMinoMethylene)aMino]thiazol-4-yl]- Methyl]sulphanyl]propaniMidaMide Hydrochloride |
|
|
|
2-(MethylcarbaMoyl)benzoic acid |
6843-36-3 |
C9H9NO3 |